exwannabe, that is not the trial I am referring too, its a new trial with Keytruda and DCVAX through UCLA, I will find the clinical trial but it was mentioned here a few days ago.
"we recently opened a novel clinical trial to investigate the safety and efficacy of combining a personalized dendritic cell vaccine with an anti-PD1 immune checkpoint inhibitor, said Dr. Liau"
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma